Carl Stenbratt

Carl Stenbratt, Ph.D., is a Senior Scientist at AstraZeneca, specializing in drug discovery and diverse chemical modalities. With over ten years of research experience spanning both academia and industry, Carl has contributed significantly to the field of organic chemistry and chemical biology, focusing on oligonucleotide therapeutics and RNA degradation strategies. Previously, they conducted doctoral research at the Max Planck Institute of Molecular Physiology and held various consulting positions that enhanced their expertise in medicinal chemistry. Carl's work is driven by a passion for advancing science and developing innovative medicines for future generations.